• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Cortex unveils growth plans, 1,400 new jobs

Cortex unveils growth plans, 1,400 new jobs

October 24, 2012
CenterWatch Staff

Cortex, a St. Louis-based hub of bioscience and technology R&D and commercialization, has unveiled phase two of its 25-year master plan, which will bring 1,400 new jobs and 384,000 square feet of additional lab and office space to the district.

"Ten years ago we had a vision to transform an aging 200-acre industrial area into a vibrant, technology district," said John Dubinsky, chairman of Cortex. "Cortex has since become an unquestioned success, positioning St. Louis as an emerging, national center of bioscience, technology and innovation."

Cortex was founded in 2002 with a $29 million investment from founding partners Washington University in St. Louis, BJC Healthcare, University of Missouri-St. Louis, Saint Louis University and the Missouri Botanical Garden—academic and research institutions that sought to leverage their resources and research to grow the technology industry throughout the region.

"Phase two will take Cortex to the next level, generating $186 million in new development from our founders and through a partnership with Wexford Science and Technology, a leading national research park developer,” said Dennis Lower, president and CEO of Cortex.

Wexford Science & Technology will invest more than $100 million in Cortex through the purchase of the Cortex I building and pending redevelopment of the historic Heritage warehouse property.

"We create what we call 'Knowledge Communities' that connect businesses, academic institutions and neighborhoods to drive bioscience and technology innovation," said Dan Cramer, executive vice president of Baltimore-based Wexford.

The $155 million already invested in phase one has resulted in approximately 950 technology and building management jobs and 124 housing units. Over the next 18 months, phase two will produce another $186 million of district investment. Phase two will deliver 384,000 square feet of additional lab and office space, bringing the total to over 1 million square feet of facilities on $350 million of investment since its inception.

In December, Wexford plans to purchase the historic Heritage warehouse building from Cortex and undertake a $73 million lab and office renovation, as well as contribute $7.35 million toward public infrastructure. Approximately 400 jobs will be created in the Heritage building.

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing